Header Logo

Connection

MAYA BALAKRISHNAN to Humans

Back to Details
This is a "connection" page, showing publications MAYA BALAKRISHNAN has written about Humans.
MAYA BALAKRISHNAN
Connection Strength
0.472
Humans
  1. Utilizing the Safety Huddle to Empower Residents as Safety Stewards (USHERSS). J Grad Med Educ. 2024 Jun; 16(3):355-356.
    View in: PubMed
    Score: 0.025
  2. A public health perspective on mitigating the global burden of chronic liver disease. Hepatology. 2024 02 01; 79(2):451-459.
    View in: PubMed
    Score: 0.024
  3. A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients. Am J Gastroenterol. 2024 03 01; 119(3):505-511.
    View in: PubMed
    Score: 0.024
  4. Behavioral weight-loss interventions for patients with NAFLD: A systematic scoping review. Hepatol Commun. 2023 08 01; 7(8).
    View in: PubMed
    Score: 0.023
  5. Perceptions of weight status and energy balance behaviors among patients with non-alcoholic fatty liver disease. Sci Rep. 2022 04 05; 12(1):5695.
    View in: PubMed
    Score: 0.021
  6. Perceived Barriers to Weight Loss among Hispanic Patients with Non-alcoholic Fatty Liver Disease. Hisp Health Care Int. 2022 09; 20(3):171-178.
    View in: PubMed
    Score: 0.021
  7. Sleep Disturbance Is Associated With the Presence of Portosystemic Collaterals in Patients With Compensated Cirrhosis. Hepatol Commun. 2021 03; 5(3):491-501.
    View in: PubMed
    Score: 0.020
  8. External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population. Dig Dis Sci. 2021 07; 66(7):2387-2393.
    View in: PubMed
    Score: 0.019
  9. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021 01; 19(1):61-71.e15.
    View in: PubMed
    Score: 0.019
  10. The Role of Noninvasive Tests for Differentiating NASH From NAFL and Diagnosing Advanced Fibrosis Among Patients With NAFLD. J Clin Gastroenterol. 2020 02; 54(2):107-113.
    View in: PubMed
    Score: 0.018
  11. The HCV Treatment Cascade: Race Is a Factor to Consider. J Gen Intern Med. 2019 10; 34(10):1949-1951.
    View in: PubMed
    Score: 0.018
  12. PROs of Patient-reported Outcomes?for Nonalcoholic Fatty?Liver Disease and Effects?on?Treatment for Nonalcoholic?Steatohepatitis. Clin Gastroenterol Hepatol. 2019 09; 17(10):1950-1953.
    View in: PubMed
    Score: 0.017
  13. Alcohol and the Law. Clin Liver Dis. 2019 02; 23(1):25-38.
    View in: PubMed
    Score: 0.017
  14. Management of Neonatal Abstinence Syndrome: The Importance of a Multifaceted Program Spanning Inpatient and Outpatient Care. Jt Comm J Qual Patient Saf. 2018 Jun; 44(6):309-311.
    View in: PubMed
    Score: 0.016
  15. An Investigation into the Recent Increase in Gastric Cancer in the USA. Dig Dis Sci. 2018 06; 63(6):1613-1619.
    View in: PubMed
    Score: 0.016
  16. Changing Trends in Stomach Cancer Throughout the World. Curr Gastroenterol Rep. 2017 Aug; 19(8):36.
    View in: PubMed
    Score: 0.015
  17. Obesity and Risk of Nonalcoholic Fatty Liver Disease: A Comparison of Bioelectrical Impedance Analysis and Conventionally-Derived Anthropometric Measures. Clin Gastroenterol Hepatol. 2017 12; 15(12):1965-1967.
    View in: PubMed
    Score: 0.015
  18. Hepatitis C and Risk of Nonhepatic Malignancies. Clin Liver Dis. 2017 08; 21(3):543-554.
    View in: PubMed
    Score: 0.015
  19. Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey. Dig Dis Sci. 2017 02; 62(2):526-533.
    View in: PubMed
    Score: 0.015
  20. Acculturation and Nonalcoholic Fatty Liver Disease Risk Among Hispanics of Mexican Origin: Findings From the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol. 2017 02; 15(2):310-312.
    View in: PubMed
    Score: 0.015
  21. Liver and Spleen Stiffness Measurements by Point Shear Wave Elastography via Acoustic Radiation Force Impulse: Intraobserver and Interobserver Variability and Predictors of Variability in a US Population. J Ultrasound Med. 2016 Nov; 35(11):2373-2380.
    View in: PubMed
    Score: 0.015
  22. Hepatic arteriolosclerosis: a small-vessel complication of diabetes and hypertension. Am J Surg Pathol. 2015 Jul; 39(7):1000-9.
    View in: PubMed
    Score: 0.013
  23. Prebiotics, probiotics and digestive health. Curr Opin Clin Nutr Metab Care. 2012 Nov; 15(6):580-5.
    View in: PubMed
    Score: 0.011
  24. An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients. Dig Dis Sci. 2024 Jul; 69(7):2430-2436.
    View in: PubMed
    Score: 0.006
  25. Understanding Primary Care Physician Perspectives on the Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: A Qualitative Study. Inquiry. 2024 Jan-Dec; 61:469580241241272.
    View in: PubMed
    Score: 0.006
  26. Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. J Hepatol. 2023 03; 78(3):493-500.
    View in: PubMed
    Score: 0.006
  27. The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting. Clin Gastroenterol Hepatol. 2023 05; 21(5):1252-1260.e5.
    View in: PubMed
    Score: 0.005
  28. Association of lifestyle behaviors with non-alcoholic fatty liver disease and advanced fibrosis detected by transient elastography among Hispanic/Latinos adults in the U.S. Ethn Health. 2023 02; 28(2):299-312.
    View in: PubMed
    Score: 0.005
  29. Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017-2018. Prev Med. 2022 01; 154:106903.
    View in: PubMed
    Score: 0.005
  30. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018. PLoS One. 2021; 16(6):e0252164.
    View in: PubMed
    Score: 0.005
  31. Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective. J Clin Lipidol. 2021 May-Jun; 15(3):423-430.
    View in: PubMed
    Score: 0.005
  32. MELD-Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis. Dig Dis Sci. 2021 01; 66(1):247-256.
    View in: PubMed
    Score: 0.005
  33. Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals. PLoS One. 2019; 14(3):e0211811.
    View in: PubMed
    Score: 0.004
  34. Treatment of Dyslipidemia in Common Liver Diseases. Clin Gastroenterol Hepatol. 2018 08; 16(8):1189-1196.
    View in: PubMed
    Score: 0.004
  35. Pulmonary complications in chronic liver disease. Hepatology. 2014 Apr; 59(4):1627-37.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.